Review
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease [Internet]
London: Royal College of General Practitioners (UK); 2008 May.
- PMID: 21834195
- Bookshelf ID: NBK55501
Item in Clipboard
Review
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease [Internet]
Excerpt
The scope for this guideline was limited to the identification and assessment of cardiovascular disease (CVD) risk and to the assessment and modification of lipids in people at risk of CVD or people with known cardiovascular disease. The guideline development group wishes to make it clear that lipid modification should take place as part of a programme of risk reduction and also include attention to the management of all other known risk factors.
Copyright © 2008, Royal College of General Practitioners.
Sections
- Preface
- Key priorities for implementation
- 1. Introduction
- 2. Methods
- 3. Identification and assessment of people at high risk of cardiovascular disease (CVD)
- 4. Communication of patient risk assessment and information
- 5. Lifestyle modifications for the primary and secondary prevention of CVD
- 6. Drug therapy for the primary prevention of cardiovascular disease (CVD)
- 7. Drug therapy for the secondary prevention of cardiovascular disease (CVD)
- Reference List
- Appendix A Audit Criteria
- Appendix B Scope
- Appendix C Health Economic Modelling
- Appendix D Clinical Evidence Extractions
- Appendix E Health Economic Extractions
- Appendix F Clinical Questions and Search Strategy
- Appendix G Omega-3 fatty acids content of various oily fish required to provide approximately 1 g of EPA plus DHA per day
- Appendix H Framingham Equation
- Appendix I Strategies for identification of patients at high risk of CVD in primary care
- Appendix J Expert Reviews of QRISK
- Appendix K A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease
- Appendix L Declarations of Interest – Lipid Modification Guideline Development Group
Publication types
LinkOut - more resources
Full Text Sources
